SCHEMBL30454637

SCHEMBL30454637

Cc1cc(S(=O)(=O)Cl)ccc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CCR2 P41597 1/20 0.43
IDO1 P14902 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
ABL1 P00519 1/20 0.39
RIN1 Q13671 1/20 0.39
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.36
CA2 P00918 3/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA6 P23280 2/20 0.35
CA5A P35218 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA5B Q9Y2D0 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17985 1.00 LMNA (0.47) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL7546641 0.83 LMNA (0.41) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL31689531 0.83 LMNA (0.41) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5524384 0.83 ALDH1A1 (0.50) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL394533 0.81 LMNA (0.49) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL29421567 0.81 LMNA (0.49) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL851152 0.81 CA2 (0.55) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL994541 0.80 TDP1 (0.61) LMNAALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL3194901 0.80 CA2 (0.43) ALDH1A1MEN1KMT2ATDP1HSD17B10
SCHEMBL830828 0.79 LMNA (0.51) LMNAALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532491-A1 MORPHOLINE-3-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES Nxera Pharma UK Limited (GB) 2025-04-09 EP disclosed
WO-2024028604-A1 MORPHOLINE-3-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES HEPTARES THERAPEUTICS LIMITED (GB) 2024-02-08 WO disclosed
WO-2023122778-A1 PYRIDAZINONE DERIVATIVES USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2023-06-29 WO disclosed